Navigation Links
The Results From a Clinical Trial Led by the Montreal Heart Institute Demonstrate That Drug Reduces Inflammation in Patients With Serious Cardiovascular Disease
Date:11/10/2008

MONTREAL, Nov. 10 /PRNewswire/ -- Montreal Heart Institute Research Centre Director Dr. Jean-Claude Tardif presented yesterday results from a clinical trial demonstrating that VIA-2291, an investigational drug being developed by VIA Pharmaceuticals, Inc., significantly inhibited production of leukotrienes, proposed mediators of vascular inflammation, in patients with serious heart disease. VIA-2291 was well-tolerated with no serious adverse events attributed to the drug. The study was presented in a Special Session at the American Heart Association 2008 Scientific Sessions in New Orleans, Louisiana.

The study of VIA-2291 was designed to establish optimal dosing and safety data in patients with acute coronary syndromes (ACS), who recently had a heart attack or unstable angina. 191 patients were treated once daily for 12 weeks with one of three dose levels of VIA-2291 or placebo. A sub-study of patients continued for an additional 12 weeks of treatment.

Cardiologists have several therapies that help reduce heart disease risk factors, but none that specifically target inflammation, an underlying cause of atherosclerosis, which leads to major adverse cardiac events (MACE), including heart attack and stroke.

VIA-2291 is designed to be a selective and reversible inhibitor of 5-LO, a key enzyme in the biosynthesis of leukotrienes, that are important mediators of inflammation believed to be involved in the development and progression of atherosclerosis.

"VIA-2291 has the potential to be the first drug to specifically target one cardiovascular inflammatory pathway," said Dr. Jean-Claude Tardif, the VIA-2291 ACS trial's principal investigator, director of the Montreal Heart Institute Research Centre and professor of medicine at the Universite de Montreal. "These data support further clinical development of this drug, including larger outcome trials."

Study Results

The trial demonstrated a statistically significant, dose-depende
'/>"/>

SOURCE Montreal Heart Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Chindex International Inc. Reports Second Quarter FY 2009 Financial Results
2. Warner Chilcott Reports Operating Results for the Quarter Ended September 30, 2008 and Updates 2008 Full Year Guidance
3. MGT Capital Investments Reports Third Quarter 2008 Financial Results and Provides Update on Recent Developments
4. China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results
5. Ellex Announces Six-Month Results on Retina Regeneration Therapy
6. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2008 Financial Results on Tuesday, November 11, at 8:30 A.M. EST
7. InfoLogix to Report Third Quarter Financial Results on November 10, 2008
8. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2009 Financial Results on Monday, November 10th, at 4:30 P.M. EST
9. China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
10. Fraxel(R) Laser Systems Shown to Provide Superior Results Compared to Pseudo Fractional Laser Technologies
11. NutraCea Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... If you were to create a list of ... say? Would you place a high value on charisma? Organizational ... a leadership “wish list,” the truth is that just as ... different types of leaders. But if good leaders come in ... that account for this kind of diversity? , PeopleKeys, ...
(Date:9/30/2014)... In a move that will deliver ... and management functions for sponsors, Synergy Research Group ... system. ClinCapture offers advanced out-of-the-box features that will ... trial data and avoid errors and duplications. This ... leading clinical research organization in the Russian region. ...
(Date:9/30/2014)... 2014 Miraca Life Sciences (MLS), the ... research posters at the annual meeting of the American ... its Annual Scientific Meeting and Postgraduate Course in Philadelphia, ... from Miraca Life Sciences will be at booth 711 ... Challenge. , The research posters for ACG provide a ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Pyramid ... announced today that the Department of Veterans Affairs ... as its Enterprise End User Business Intelligence platform. ... support our nation’s veterans by enabling more than ... BI Office’s powerful enterprise analytics and reporting capabilities. ...
(Date:9/30/2014)... Signet Puerto Rico, a leading ... Juan, Puerto Rico, leverages RamSoft’s PowerServer RIS/PACS/PM™ to ... Souffront, site Administrator for Signet Puerto Rico, explains ... to bring in PowerServer RIS/PACS/PM because we will ... physician satisfaction while reducing our costs of delivering ...
Breaking Medicine News(10 mins):Health News:Personality Plays a Key Role in Leadership Development 2Health News:Personality Plays a Key Role in Leadership Development 3Health News:Synergy Research Group Opts for Clinovo 2Health News:Synergy Research Group Opts for Clinovo 3Health News:Miraca Life Sciences Research Institute to Present Eight GI Pathology Research Studies at Annual Meeting of American College of Gastroenterologists 2Health News:U.S. Department of Veterans Affairs Takes Its Analytic Capabilities to the Next Level with BI Office from Pyramid Analytics 2Health News:Signet Puerto Rico Leverages PowerServer RIS/PACS/PM™ to Improve Patient Care, Cut Costs 2
... , NEWARK, N.J., Aug. 6 /PRNewswire-USNewswire / -- ... New Jersey throughout the week of August 9-15 at various cities ... information on programs that provide prescription medicines for free or nearly ... compared to 5.1% a year ago -- the Partnership for Prescription ...
... , NEW YORK, Aug. 6 Care to ... announced today that is has been awarded Full Accreditation in ... nonprofit health care accrediting organization. , , ... of health care management through processes of accreditation and education. ...
... , UNITED NATIONS, Aug. 6 ... Population Fund, are critical to enhancing efforts to reduce maternal ... Representatives of more than 40 international faith-based organizations emphasized ... a policy round table on a range of issues including ...
... Monographs addressing individual mandates, tax exclusion and a public ... of Physicians (ACP). The new policy papers are: ... , Reforming the Tax Exclusion for Health Insurance, A ... "These monographs provide an evidence-based analysis of ...
... , , NEW YORK, Aug. ... now confirmed that America is in a national obesity crisis. More ... America,s well-being, not only as individuals, but as a country. , ... powerful nation when we join together and take a stand. More ...
... , SOUTH PASADENA, Calif., Aug. 6 ... free-standing multi-specialty cancer center in South Pasadena. The 22,000 s.f. ... provide outpatient services in medical, surgical and radiation ... kind in the San Gabriel Valley to offer RapidArc((TM)), a ...
Cached Medicine News:Health News:Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 2Health News:Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 3Health News:Partnership for Prescription Assistance Prepared to Help New Jersey Workers Hurt by Recession 4Health News:Care to Care Receives Full URAC Health Utilization Management Accreditation 2Health News:Care to Care Receives Full URAC Health Utilization Management Accreditation 3Health News:Cooperation Between Faith-Based Organizations and UNFPA Critical to Maternal Health, Say Groups 2Health News:Internists tackle key health reform issues 2Health News:Internists tackle key health reform issues 3Health News:America Takes on the Challenge to Fight Obesity 2Health News:America Takes on the Challenge to Fight Obesity 3Health News:America Takes on the Challenge to Fight Obesity 4Health News:California Cancer Specialists Medical Group, Inc. Opens Outpatient Cancer Center in South Pasadena, Calif., With Renowned Medical Staff, State-of-the-Art Technology 2
(Date:9/29/2014)...  On Oct. 2, some 24,000 Lilly employees spanning ... Global Day of Service. Building on Lilly,s strong heritage ... a single, coordinated effort to improve the communities where ... so proud of this tradition, and of our Lilly ... the communities around the world where we live and ...
(Date:9/29/2014)... 2014 Kush Bottles, North America,s ... and consulting services for the medical and recreational marijuana ... has assumed the role of Chief Executive Officer. ... and worked as COO until February of 2014, returned ... other ventures. His return marks a clear dedication to ...
(Date:9/29/2014)... , Sept. 29, 2014  ADM Tronics ... it has entered into an affiliation with Triotech ... Cambridge, Massachusetts founded by ... member of ADMT,s Advisory Board. The ... technology companies with specialized services and finances to ...
Breaking Medicine Technology:Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 2Lilly's seventh Global Day of Service rallies 24,000 employees in nearly 60 countries 3Kush Bottles Co-Founder Steps into Role of CEO 2ADM Tronics Joins Triotech Ventures Technology Consortium 2ADM Tronics Joins Triotech Ventures Technology Consortium 3
... lenses and frames are designed with the safety ... lenses are Schott RS-520 (also called SF-6) leaded ... These lenses meet standards, as set for optical ... ,While our eyewear is protecting your eyes, ...
... Protection Goggles fit over ... used by the whole ... glass, 1.0 mm leaded ... increased scatter radiation protection. ...
... Jarrod Goggles have set the standard ... soft silicone saddle nose bridge. Monel ... and lasts longer. Adjustable elastic headband ... breakable plastic strap clips. 0.75 mm ...
QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
Medicine Products: